Leadership changes, October 2026

Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.

Updated Nov 6, 2026

Changes

1,035

Appointments

576

Departures

Browse by role

October 2026

Get new CFO appointments the day the filing lands.

Start alerts

Leadership changes, October 2026
Filing date	Company	Person	Role	Change	Effective date	Source
Oct 9, 2026	IRulya Therapeutics Inc.	June Bray	directordirector	Departed	Oct 8, 2026	SEC 8-K
Oct 9, 2026	IRulya Therapeutics Inc.	David Lamond	directordirector	Departed	Oct 8, 2026	SEC 8-K
Oct 9, 2026	IRulya Therapeutics Inc.	Christopher Senner	directordirector	Departed	Oct 8, 2026	SEC 8-K
Oct 9, 2026	IRulya Therapeutics Inc.	Catherine M. Bonuccelli	Class I director and as a member of the Audit Committee and Compensation CommitteeClass I director and as a member of the Audit Committee and Compensation Committee	Appointed	Oct 8, 2026	SEC 8-K
Oct 9, 2026	IRulya Therapeutics Inc.	Leone Patterson	Class III director and as chair of the Audit Committee and as chair of the Compensation CommitteeClass III director and as chair of the Audit Committee and as chair of the Compensation Committee	Appointed	Oct 8, 2026	SEC 8-K
Oct 9, 2026	IRulya Therapeutics Inc.	James Valentine	Class I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance CommitteeClass I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance Committee	Appointed	Oct 8, 2026	SEC 8-K
Oct 9, 2026	IRulya Therapeutics Inc.	Drayton Wise	Class II director and as a member of the Nominating and Corporate Governance CommitteeClass II director and as a member of the Nominating and Corporate Governance Committee	Appointed	Oct 8, 2026	SEC 8-K
Oct 9, 2026	MARZETTI CO	Tanya Berman	President of Retail Division of T. Marzetti CompanyPresident	Departed	Oct 6, 2026	SEC 8-K
Oct 9, 2026	MITEK SYSTEMS INC	Michael E. Diamond	Senior Vice President of Sales, Check VerificationSenior Vice President of Sales, Check Verification	Departed	Dec 8, 2026	SEC 8-K
Oct 9, 2026	MSG Rangers Corp.	Joseph M. Cohen	directordirector	Appointed	Oct 9, 2026	SEC 8-K
Oct 9, 2026	MYRIAD GENETICS INC	Brian Donnelly	Chief Commercial OfficerChief Commercial Officer	Departed	Sep 16, 2026	SEC 8-K
Oct 9, 2026	NextBoat Inc.	Chad Corbin	Chief Financial OfficerCFO	Departed	n/a	SEC 8-K
Oct 9, 2026	Phoenix Education Partners, Inc.	Michael Cochran	interim Chief Financial OfficerCFO	Appointed	Oct 10, 2026	SEC 8-K
Oct 9, 2026	Plum Acquisition Corp. IV	Aidin Aghamiri	member of the Company's board of directorsmember of the Company's board of directors	Departed	Oct 6, 2026	SEC 8-K
Oct 9, 2026	POOL CORP	Kenneth G. St. Romain	Senior Vice PresidentSenior Vice President	Departed	Dec 31, 2026	SEC 8-K
Oct 9, 2026	QUANTUM CORP /DE/	William H. White	Chief Financial Officer and Principal Financial OfficerCFO	Departed	Oct 9, 2026	SEC 8-K
Oct 9, 2026	QUANTUM CORP /DE/	Hiral A. Patel	Principal Financial OfficerPrincipal Financial Officer	Appointed	Oct 9, 2026	SEC 8-K
Oct 9, 2026	Satellogic Inc.	Dustin Greer	Interim Chief Financial OfficerCFO	Appointed	n/a	SEC 8-K
Oct 9, 2026	STANDARD MOTOR PRODUCTS, INC.	Nathan R. Iles	Chief Financial OfficerCFO	Departed	Oct 30, 2026	SEC 8-K
Oct 9, 2026	STANDARD MOTOR PRODUCTS, INC.	James J. Burke	Interim Chief Financial OfficerCFO	Appointed	Oct 30, 2026	SEC 8-K

Sort:Filing date ↓Company Role

IRulya Therapeutics Inc.Departed
June Bray director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
IRulya Therapeutics Inc.Departed
David Lamond director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
IRulya Therapeutics Inc.Departed
Christopher Senner director
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
IRulya Therapeutics Inc.Appointed
Catherine M. Bonuccelli Class I director and as a member of the Audit Committee and Compensation Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
IRulya Therapeutics Inc.Appointed
Leone Patterson Class III director and as chair of the Audit Committee and as chair of the Compensation Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
IRulya Therapeutics Inc.Appointed
James Valentine Class I director and as a member of the Audit Committee and as chair of the Nominating and Corporate Governance Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
IRulya Therapeutics Inc.Appointed
Drayton Wise Class II director and as a member of the Nominating and Corporate Governance Committee
Filed Oct 9, 2026Effective Oct 8, 2026SEC 8-K
MARZETTI CODeparted
Tanya Berman President
Filed Oct 9, 2026Effective Oct 6, 2026SEC 8-K
MITEK SYSTEMS INCDeparted
Michael E. Diamond Senior Vice President of Sales, Check Verification
Filed Oct 9, 2026Effective Dec 8, 2026SEC 8-K
MSG Rangers Corp.Appointed
Joseph M. Cohen director
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
MYRIAD GENETICS INCDeparted
Brian Donnelly Chief Commercial Officer
Filed Oct 9, 2026Effective Sep 16, 2026SEC 8-K
NextBoat Inc.Departed
Chad Corbin CFO
Filed Oct 9, 2026SEC 8-K
Phoenix Education Partners, Inc.Appointed
Michael Cochran CFO
Filed Oct 9, 2026Effective Oct 10, 2026SEC 8-K
Plum Acquisition Corp. IVDeparted
Aidin Aghamiri member of the Company's board of directors
Filed Oct 9, 2026Effective Oct 6, 2026SEC 8-K
POOL CORPDeparted
Kenneth G. St. Romain Senior Vice President
Filed Oct 9, 2026Effective Dec 31, 2026SEC 8-K
QUANTUM CORP /DE/Departed
William H. White CFO
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
QUANTUM CORP /DE/Appointed
Hiral A. Patel Principal Financial Officer
Filed Oct 9, 2026Effective Oct 9, 2026SEC 8-K
Satellogic Inc.Appointed
Dustin Greer CFO
Filed Oct 9, 2026SEC 8-K
STANDARD MOTOR PRODUCTS, INC.Departed
Nathan R. Iles CFO
Filed Oct 9, 2026Effective Oct 30, 2026SEC 8-K
STANDARD MOTOR PRODUCTS, INC.Appointed
James J. Burke CFO
Filed Oct 9, 2026Effective Oct 30, 2026SEC 8-K